ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1093

Single-Nucleus RNA Sequencing Reveals Cellular Heterogeneity and Cell-Cell Interactions Contributing to Tertiary Lymphoid Tissue Development in the Aged Injured Kidney

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Yoshikawa, Takahisa, Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
  • Oguchi, Akiko, Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
  • Toriu, Naoya, Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
  • Sato, Yuki, Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
  • Yamamoto, Takuya, Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Kyoto, Japan
  • Murakawa, Yasuhiro, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Kyoto, Japan
  • Yanagita, Motoko, Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan

Group or Team Name

  • Yanagita Group.
Background

Tertiary lymphoid tissues (TLTs) are ectopic lymphoid structures that develop in non-lymphoid organs with chronic inflammation. TLTs can develop in kidney diseases such as IgA nephropathy and transplanted kidneys and are associated with poor renal prognosis. However, how TLTs affect renal tissues and expand remains unclear.

Methods

Single-nucleus RNA-sequencing (snRNA-seq) was performed on three aged mouse kidneys with TLTs after ischemia–reperfusion injury or an aged kidney after sham surgery. The results were validated using immunostaining, in situ hybridization (ISH) of murine and human kidneys, and in vitro experiments.

Results

snRNA-seq identified 15,986 and 7,485 nuclei in the injured kidneys and the sham-treated kidney, respectively. In the injured kidneys, proinflammatory and profibrotic Vcam1+ injured proximal tubules (PTs) with activation of NFκB and interferon (IFN)-inducible transcription factors were detected. Importantly, VCAM1+ PTs were preferentially localized around TLTs and suggested to drive inflammation and fibrosis via the expression of multiple chemokines or cytokines. snRNA-seq analysis and ISH revealed that Tnf and Ifng were highly expressed by lymphocytes within TLTs, and these inflammatory cytokines synergistically upregulated VCAM1 and chemokine expression in cultured PT cells. In addition, snRNA-seq and immunostaining identified proinflammatory and profibrotic fibroblasts, which resided within and outside TLTs, respectively. Proinflammatory fibroblasts with STAT1 activation expressed various chemokines or cytokines, including Cxcl9/Cxcl10 and Tnfsf13b (encoding B cell-activating factor), suggesting their contribution to lymphocyte recruitment and survival. IFNγ upregulated the expression of these molecules in cultured fibroblasts in a STAT1-dependent manner, indicating potential bidirectional interactions between proinflammatory fibroblasts and IFNγ-producing CXCR3+ T cells within TLTs. These cellular and molecular components were confirmed in human transplanted kidneys with TLTs.

Conclusion

TLTs develop via intense interactions between proinflammatory renal parenchymal and immune cells. These interactions may serve as novel therapeutic targets in kidney diseases with TLT formation.

Funding

  • Government Support – Non-U.S.